Rapamycin impairs beta-cell proliferation in vivo.

Rapamycin impairs beta-cell proliferation in vivo.

Item
http://www.wikidata.org/entity/Q46676115
Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and BeyondThe required beta cell research for improving treatment of type 2 diabetesThe two faces of miR-29Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell TransplantationRapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity.Rapamycin prevents and breaks the anti-CD3-induced tolerance in NOD mice.Critical roles for the TSC-mTOR pathway in β-cell function.mTORC1 signaling in energy balance and metabolic disease.Regeneration of pancreatic beta-cell mass for the treatment of diabetes.Coupling nutrient sensing to metabolic homoeostasis: the role of the mammalian target of rapamycin complex 1 pathway.Growth factor, energy and nutrient sensing signalling pathways in metabolic ageing.
P2860

Rapamycin impairs beta-cell proliferation in vivo.

Item
http://www.wikidata.org/entity/Q46676115
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Rapamycin impairs beta-cell proliferation in vivo.
@en
Rapamycin impairs beta-cell proliferation in vivo.
@nl
type
label
Rapamycin impairs beta-cell proliferation in vivo.
@en
Rapamycin impairs beta-cell proliferation in vivo.
@nl
prefLabel
Rapamycin impairs beta-cell proliferation in vivo.
@en
Rapamycin impairs beta-cell proliferation in vivo.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Rapamycin impairs beta-cell proliferation in vivo
@en
P2093
P304
P31
P356
10.1016/J.TRANSPROCEED.2008.02.011
P407
P433
P478
P50
P577
P698